Key result
Intracoronary administration of isosorbide dinitrate induced severe coronary slow flow and transient ST-segment elevation with mild chest pain in a patient with congestive heart failure.
Case Report (n=1)
Intracoronary isosorbide dinitrate may paradoxically induce severe coronary slow flow and transient ST-segment elevation in patients with congestive heart failure, potentially due to microvascular dysfunction.
Nitroglycerin is one of the most widely used drugs in the treatment of angina. However, nitroglycerin fails to relieve angina in patients with syndrome X who have microvessel dysfunction. Microvessel function is impaired in several diseases. In this article, the authors report that despite normal coronary angiograms at control, intracoronary administration of isosorbide dinitrate induced severe coronary slow flow and transient ST-segment elevation with mild chest pain in a patient with congestive heart failure. The authors speculated that functional stenosis and a delay in the dilatation of microvessels less than 100 microm in diameter because of their dysfunction resulted in a severely slow flow after intracoronary administration of isosorbide dinitrate.
No takes yet. Share an insight, caveat, or question.
Yamashita et al. (2008) conducted a case report in Congestive heart failure (n=1). Intracoronary isosorbide dinitrate was evaluated on Coronary slow flow and transient ST-segment elevation. Intracoronary administration of isosorbide dinitrate induced severe coronary slow flow and transient ST-segment elevation with mild chest pain in a patient with congestive heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: